Dr Reddys Laboratories Share Price Today - Live Blog for May 27, 2025

After a notable 0.12% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,243.95. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

After a notable 0.03% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,244.10. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd's shares experienced a 0.25% uptick, and they are currently valued at ₹1,245.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.03% boost, with the current market value at ₹1,241.90 per share. This surge has not gone unnoticed by investors.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.02% increase and currently trading at ₹1,241.40 per share. Investors are taking notice of this upward momentum.

The share price of Dr Reddys Laboratories Ltd plunged by -0.16%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,242.50, but investors are assessing whether this is a temporary dip or a long-term trend.

The share price of Dr Reddys Laboratories Ltd experienced a -0.07% slump and is currently trading at ₹1,244.55. While the stock maintains a PE ratio of 18.0400, the industry PE is 34.0497, raising questions about valuation.

Following a noteworthy 0.05% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,245.20. When it comes to valuation, this stock has a PE ratio of 18.0400, with the industry PE ratio at 34.0497.

Dr Reddys Laboratories Ltd stock price decreased by -0.06%, with the current market value at ₹1,244.60 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.11%, reaching the current market price of ₹1,245.15. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has fallen by -0.21%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,243.80, and market participants are assessing the implications. The stock has a PE ratio of 18.0400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.04% dip in its share price and is currently trading at ₹1,245.35. The stock has a PE ratio of 18.0400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.10%, with its current market value per share resting at ₹1,245.90. This development highlights the stock's appeal to investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.03% drop, and it's now trading at ₹1,244.70 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.07%. At this moment, it's actively trading at ₹1,246.25, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd's share price has fallen by -0.11%, a situation worth noting. At present, the stock is trading at ₹1,245.15. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.0400, while the industry PE ratio is 34.0497.

Dr Reddys Laboratories Ltd shares experienced a -0.07% reduction, with the current market price at ₹1,244.40. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's share price has dropped by -0.07%, a development that warrants careful analysis. Presently trading at ₹1,244.40, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd's share price has fallen by -0.18%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,246.05, and market participants are assessing the implications. The stock has a PE ratio of 18.0400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price surged by 0.26%. With its current market price standing at ₹1,247.35 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's stock has surged by 0.06%, and it is currently trading at ₹1,245.55. Additionally, the stock maintains a PE ratio of 18.0400, while the industry PE is 34.0497.

With a remarkable 0.39% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,244.80. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.0400, while the industry's PE ratio is 34.0497.

Dr Reddys Laboratories Ltd experienced a -0.19% downturn in its share price, and it's currently trading at ₹1,240.00. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd shares experienced a -0.02% reduction, with the current market price at ₹1,243.80. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.09%, a situation worth noting. At present, the stock is trading at ₹1,243.30. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.0400, while the industry PE ratio is 34.0497.

Demonstrating a commendable 0.10% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,245.30. In terms of valuation, the stock maintains a PE ratio of 18.0400, while the industry PE ratio stands at 34.0497.